Insider Trading: Alexion Pharmaceuticals Inc (ALXN.OQ)

ALXN.OQ on NASDAQ Stock Exchange Global Select Market

173.08USD
23 Jul 2014
Price Change (% chg)

$5.11 (+3.04%)
Prev Close
$167.97
Open
$168.65
Day's High
$173.49
Day's Low
$168.26
Volume
625,246
Avg. Vol
470,306
52-wk High
$185.06
52-wk Low
$102.33

Search Stocks
DUBIN THOMAS I H Options Exercised: 0
Trade Date: Thursday, 26 Jul 2012 Price: 105.76
Title: Officer Shares Held: 99,233
Type Traded: Direct Net Change in Shares This Filing: -1,348

Institutional Holders

% Shares Owned: 97.59%
# of Holders: 671
Total Shares Held: 193,029,454
3 Mo. Net Change: -316,318
# New Positions: 11
# Closed Positions: 10
# Increased Positions: 39
# Reduced Positions: 51
# Net Buyers: -12

Officers & Directors

Name Age Since Current Position

Max Link

79 2002 Independent Chairman of the Board

Leonard Bell

55 2002 Chief Executive Officer, Treasurer, Director

Vikas Sinha

50 2012 Chief Financial Officer, Executive Vice President

Stephen Squinto

57 2013 Chief Global Operations Officer, Executive Vice President

Clare Carmichael

54 2011 Chief Human Resource Officer, Senior Vice President

David Hallal

47 2012 Executive Vice President, Chief Commercial Officer

Martin Mackay

57 2013 Executive Vice President, Global Head - Research and Development

John Moriarty

46 2012 Senior Vice President, General Counsel

Saqib Islam

44 2013 Senior Vice President, Chief Strategy and Portfolio Officer

Frank Wright

66 2013 Senior Vice President; President of Alexion Pharma International Sarl

John Mollen

63 2014 Director

David Brennan

60 2014 Independent Director

M. Michele Burns

56 2014 Independent Director

Christopher Coughlin

62 2014 Independent Director

William Keller

2009 Independent Director

R. Douglas Norby

78 1999 Independent Director

Alvin Parven

73 1999 Independent Director

Andreas Rummelt

2010 Independent Director

Ann Veneman

65 2010 Independent Director
Search Stocks